Fasenra (benralizumab) has an elimination half-life of approximately 15 days, meaning it takes about 75 days (roughly 2.5 months) for the drug to be essentially cleared from your bloodstream. However, its biological effects on your immune cells last considerably longer than the drug itself, with full recovery taking up to 6 months after your last dose.
How the Drug Leaves Your Body
Every 15 days, your body eliminates roughly half of the remaining Fasenra in your system. After one half-life, 50% remains. After two half-lives (30 days), 25% remains. Pharmacologists generally consider a drug fully cleared after five half-lives, which puts the total clearance window at about 75 days, or just under 11 weeks.
Your age can shift this timeline modestly. In adolescents (ages 12 to 17), the half-life runs closer to 14 days. In adults 18 to 64, it’s about 15 days. In older adults (65 to 75), it stretches to around 17 days, meaning full clearance could take closer to 12 weeks. Body weight also plays a role: people with higher body weight clear the drug faster because they have larger volumes of distribution. Age, sex, race, liver function, and kidney function do not meaningfully change how quickly Fasenra is eliminated.
Why Its Effects Outlast the Drug Itself
Fasenra works differently from most medications. Rather than blocking a chemical signal, it binds directly to a receptor on eosinophils (a type of white blood cell involved in asthma and allergic inflammation) and triggers your immune system’s natural killer cells to destroy them. Macrophages then clean up the debris. This is a more aggressive approach than other eosinophil-targeting biologics, which simply block the signal that tells your body to make more eosinophils.
The result is near-complete eosinophil depletion. Within 24 hours of a dose, blood eosinophil counts typically drop by 95% or more. Because Fasenra physically eliminates these cells rather than just suppressing their production, your body needs time to rebuild its eosinophil population from scratch. Eosinophil counts remain suppressed for at least 8 weeks after your last dose, and most people see their levels return to roughly baseline within 6 months of stopping treatment. That 6-month window is the more practical answer if you’re thinking about how long Fasenra’s presence is truly “felt” in your system.
What This Means for Switching Biologics
If you’re transitioning from Fasenra to a different biologic for asthma or another condition, the extended biological effect matters more than the drug’s physical clearance. No formal drug interaction studies have been conducted with Fasenra, but the drug does not use the liver’s standard enzyme pathways for metabolism and doesn’t appear to alter levels of commonly co-administered medications. Your doctor will likely factor in both the 75-day clearance estimate and the longer eosinophil recovery timeline when planning any switch.
The Dosing Schedule Reflects the Half-Life
Fasenra’s dosing pattern makes more sense once you understand its half-life. You receive the first three doses every 4 weeks to build up drug levels quickly, then shift to one injection every 8 weeks for maintenance. The loading phase ensures eosinophils are depleted rapidly, while the 8-week maintenance interval works because the drug’s slow elimination keeps enough in your system to sustain that depletion between doses. Even at the tail end of an 8-week cycle, residual Fasenra continues suppressing eosinophil recovery.
If You Miss a Dose
The 15-day half-life also means a missed dose doesn’t cause an immediate loss of effect. Your eosinophil levels won’t snap back overnight. That said, the manufacturer’s guidance is simply to contact your healthcare provider if you miss a scheduled injection so they can determine the best time to resume your dosing cycle. Because steady-state drug levels depend on consistent timing, getting back on schedule matters for long-term asthma control.